Thu, 26 Apr 2018 12:00:00 EDT Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition Conditions: Diabetes Mellitus, Type 2; Pre-diabetic; Hypertension; Elevated Blood Pressure Interventions: Drug: Sacubitril/Valsartan 200mg (blinded); Drug: Valsartan 160mg (blinded) Sponsor: University of Pennsylvania Not yet recruiting
Thu, 26 Apr 2018 12:00:00 EDT PeRsOnalising Treatment Of Diabetic Nephropathy: Conditions: Diabetes Mellitus, Type 1; Diabetes Complications; Diabetic Nephropathies Intervention: Sponsor: Peter Rossing Completed
Thu, 26 Apr 2018 12:00:00 EDT Prebiotic Fiber in the ICU Condition: Sepsis Interventions: Dietary Supplement: High Fiber; Dietary Supplement: Low Fiber Sponsors: Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Thu, 26 Apr 2018 12:00:00 EDT Sleep Apnea Syndrome in Obese Women During Pregnancy Conditions: Apnea, Obstructive Sleep; Pregnancy Complications; Pre-Eclampsia; Obesity Intervention: Diagnostic Test: polysomnography Sponsor: University Hospital, Lille Recruiting
Wed, 25 Apr 2018 12:00:00 EDT Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT) Conditions: Proliferative Diabetic Retinopathy; VEGF Overexpression Interventions: Drug: IVC; Procedure: Blood and aqueous humor at the time of IVC; Procedure: Collect blood, aqueous humor, and initial vitreous at the time of surgery.; Procedure: IVC-sham Sponsor: The First Affiliated Hospital with Nanjing Medical University Recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
Diabetes news from the American Diabetes Association
